Health & Medicine Moderate evidence
Survodutide reduced weight more than placebo in a 76-week obesity trial
The drug produced double-digit average weight loss, while gastrointestinal side effects were frequent and discontinuation matters.
Comprehensive research hub
Metabolism & Obesity Research
Drug trials, nutrition, diabetes and metabolic health, with weight change separated from long-term health outcomes and individualized medical advice.
2studies analyzed
2human studies
2randomized trials
0systematic reviews
0animal studies
What this hub covers
- GLP-1 and related drug trials
- Diabetes care
- Nutrition and metabolism
- Weight-maintenance evidence
Questions we ask
- What happens after treatment stops?
- Who was excluded from the trial?
- Were cardiovascular outcomes measured?
Latest and foundational evidence
Research connected to this topic
Health & Medicine Moderate evidence
Intensive physician role-play training improved six-month diabetes control
Patients of trained physicians reached HbA1c targets more often, but the intervention tested implementation—not a new diabetes treatment.